BriaCell Therapeutics Corp.
General ticker "BCTX" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $90.3M (TTM average)
BriaCell Therapeutics Corp. does not follow the US Stock Market performance with the rate: -20.4%.
Estimated limits based on current volatility of 6.2%: low 10.84$, high 12.28$
Factors to consider:
- Earnings expected soon, date: 2025-12-15 bmo
- Total employees count: 17 (+6.2%) as of 2024
- Top business risk factors: Going concern, Insufficient funding, Economic downturns and volatility, Third-party risks, Labor/talent shortage/retention
- Price in estimated range
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-07-31 to 2027-07-31
- 2025-07-31 to 2026-07-31 estimated range: [5.53$, 25.99$]
- 2026-07-31 to 2027-07-31 estimated range: [2.56$, 12.05$]
Financial Metrics affecting the BCTX estimates:
- Negative: with PPE of -0.1 at the end of fiscal year the price was high
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -1153.61 <= 0.33
- Negative: negative Net income
- Negative: negative Industry operating cash flow (median)
- Positive: Shareholder equity ratio, % of 82.59 > 63.39
- Negative: negative Industry operating income (median)
- Positive: Industry inventory ratio change (median), % of 0 <= 0
Short-term BCTX quotes
Long-term BCTX plot with estimates
Financial data
| YTD | 2023-07-31 | 2024-07-31 | 2025-07-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $31.26MM | $45.54MM | $37.73MM |
| Operating Income | $-31.26MM | $-45.54MM | $-37.73MM |
| Non-Operating Income | $3.99MM | $38.81MM | $0.90MM |
| Interest Expense | $0.00MM | $0.00MM | $0.05MM |
| R&D Expense | $20.60MM | $37.14MM | $29.50MM |
| Income(Loss) | $-27.27MM | $-6.74MM | $-36.83MM |
| Profit(Loss)* | $-27.27MM | $-6.41MM | $-36.50MM |
| Stockholders Equity | $-5.04MM | $-3.31MM | $24.58MM |
| Assets | $36.28MM | $8.15MM | $29.77MM |
| Operating Cash Flow | $-23.74MM | $-24.13MM | $-39.07MM |
| Capital expenditure | $0.00MM | $0.62MM | $0.00MM |
| Investing Cash Flow | $0.00MM | $-0.68MM | $-10.61MM |
| Financing Cash Flow | $3.95MM | $4.42MM | $63.04MM |
| Earnings Per Share** | $-26.19 | $-5.84 | $-86.25 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.